QuickView for eukaryotic initiation factor 4G binding (biogroup)

1. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
2. L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
3. OMIM - Autistic disorder
4. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
5. L1000 CMAP - Neuroblastoma SH-SY5Y cells with shRNA-mediated gene knockdown

1. The silencing domain of GW182 interacts with PABPC1 to promote translational repression and degradat…
2. Mnk is a negative regulator of cap-dependent translation in Aplysia neurons.

There were no clinical trials for eukaryotic initiation factor 4G binding